{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:42:41Z","timestamp":1770277361447,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,8]]},"DOI":"10.7759\/cureus.41561","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T14:14:32Z","timestamp":1688825672000},"source":"Crossref","is-referenced-by-count":2,"title":["Primary Central Nervous System Lymphoma Presenting as Isolated Multiple Cranial Neuropathies: An Extremely Rare Case"],"prefix":"10.7759","author":[{"given":"Geoffrey  B","family":"Lobban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Basta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsiaryna","family":"Laziuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Kulhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes C","year":"2017","unstructured":"Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017, 35:2410-8. 10.1200\/JCO.2017.72.7602","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000435302.02895.f3","article-title":"Primary leptomeningeal lymphoma: international primary CNS lymphoma collaborative group report","volume":"81","author":"Taylor JW","year":"2013","unstructured":"Taylor JW, Flanagan EP, O'Neill BP, et al.. Primary leptomeningeal lymphoma: international primary CNS lymphoma collaborative group report. Neurology. 2013, 81:1690-6. 10.1212\/01.wnl.0000435302.02895.f3","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2278-330X.221341","article-title":"Primary central nervous system lymphoma in immunocompetent patients: a regional cancer center experience","volume":"6","author":"Rudresha AH","year":"2017","unstructured":"Rudresha AH, Chaudhuri T, Lakshmaiah KC, Babu G, Lokesh KN, Rajeev LK. Primary central nervous system lymphoma in immunocompetent patients: a regional cancer center experience. South Asian J Cancer. 2017, 6:165-8. 10.4103\/2278-330X.221341","journal-title":"South Asian J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille B","year":"2000","unstructured":"Bataille B, Delwail V, Menet E, et al.. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000, 92:261-6. 10.3171\/jns.2000.92.2.0261","journal-title":"J Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen IS","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011, 32:984-92. 10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.036","article-title":"Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07","volume":"21","author":"Batchelor T","year":"2003","unstructured":"Batchelor T, Carson K, O'Neill A, et al.. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol. 2003, 21:1044-9. 10.1200\/JCO.2003.03.036","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri AJ","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, et al.. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003, 21:266-72. 10.1200\/JCO.2003.09.139","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel E","year":"2010","unstructured":"Thiel E, Korfel A, Martus P, et al.. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol. 2010, 11:1036-47. 10.1016\/S1470-2045(10)70229-1","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/aol-20-47","article-title":"Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies","volume":"5","author":"Schaff LR","year":"2021","unstructured":"Schaff LR, Ambady P, Doolittle ND, Grommes C. Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies. Ann Lymphoma. 2021, 5:8. 10.21037\/aol-20-47","journal-title":"Ann Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24204","article-title":"Rituximab with high-dose methotrexate in primary central nervous system lymphoma","volume":"90","author":"Kansara R","year":"2015","unstructured":"Kansara R, Shenkier TN, Connors JM, Sehn LH, Savage KJ, Gerrie AS, Villa D. Rituximab with high-dose methotrexate in primary central nervous system lymphoma. Am J Hematol. 2015, 90:1149-54. 10.1002\/ajh.24204","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/165979-primary-central-nervous-system-lymphoma-presenting-as-isolated-multiple-cranial-neuropathies-an-extremely-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:57Z","timestamp":1707508977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/165979-primary-central-nervous-system-lymphoma-presenting-as-isolated-multiple-cranial-neuropathies-an-extremely-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.41561","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,8]]}}}